# Rosuvastatin

## Crestor 10mg

| TAH Drug Code      | [OCRE](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCRE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet & other non-pharmacological measures are inadequate. Treatment of homozygous familial hypercholesterolaemia, either alone or as an adjunct to diet & other non-pharmacological (e.g. exercise, weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. |
| Dosing             | Adult and children (10-17 years): 5-20 mg orally once daily with or without food.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Active liver disease including unexplained, persistent elevations of serum transaminases & any serum transaminase elevation exceeding 3 times the upper limit of normal; severe renal impairment (creatinine clearance <30 mL/min), myopathy; patients on concomitant cyclosporin; pregnancy & lactation.                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Constipation, nausea, abdominal pain, headache, dizziness, myalgia, asthenia. Gastrointestinal: Abdominal pain (2.4% ), Nausea (2% to 3.4% ) Musculoskeletal: Arthralgia (10.1% ), Myalgia (2.8% to 12.7% , ) Neurologic: Asthenia (0.9% to 4.7% ), Headache (3.1% to 5.5% ) Renal: Urinary tract infectious disease (2.3% .)                                                                                                                                                                                                                                                                 |
| Pregnancy          | Contraindicated â€“ 1st Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/rosuvastatin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

